Brian Powl - Sep 27, 2025 Form 4 Insider Report for Kura Oncology, Inc. (KURA)

Role
Chief Commercial Officer
Signature
Thomas Doyle, Attorney-in-fact for Brian Powl
Stock symbol
KURA
Transactions as of
Sep 27, 2025
Transactions value $
-$79,505
Form type
4
Date filed
9/29/2025, 07:30 PM
Previous filing
Jan 28, 2025
Next filing
Nov 14, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Powl Brian T. Chief Commercial Officer C/O KURA ONCOLOGY, INC., 12730 HIGH BLUFF DRIVE, SUITE 400, SAN DIEGO Thomas Doyle, Attorney-in-fact for Brian Powl 2025-09-29 0001934232

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KURA Common Stock Award $0 +48.9K +81.95% $0.00 109K Sep 27, 2025 Direct
transaction KURA Common Stock Sale -$79.5K -8.89K -8.19% $8.94 99.7K Sep 29, 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Sell-to cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 9/27/25.